Aspire Biopharma Holdings, Inc
Price
FilingsNewest: 8-K, Auditor changeSep 29 →InsidersNo open-market buys or sales.→HoldersJane Street 1.1%Geode 0.8%Vanguard 0.8%→Financing →PeersClosest companies: ZSQR, ABVC, PHIO→
From the filings
Figures
- Revenue
- $97,659last 12 months
- Net income
- −$11.0Mlast 12 months
- Operating cash flow
- −$6.2Mlast 12 months
- Cash and equivalents
- $12.2Mat the last balance sheet
- Shares outstanding
- 1.3M shareson issue